ENTITY
Transcenta Holding

Transcenta Holding (6628 HK)

9
Analysis
Health CareChina
Transcenta Holding Limited operates as a global biotherapeutics company. The Company develops therapeutic antibody molecules for oncology and selected non-oncology indications including bone and kidney disorders. Transcenta Holding provides services in China.
more
Refresh
27 Mar 2022 09:15

China Healthcare Weekly (Mar.25)- Viable Business Model for Pharma, CXO for CGT, China Sleep Economy

The strategy of Eli Lilly could be a good reference for domestic pharmaceutical companies.CXO for CGT is a better investment option.The sleep...

Logo
276 Views
Share
21 Oct 2021 09:05

Pre-IPO Beijing Mabworks Biotech - MIL62 Alone Cannot Save the Situation

This article mainly analyzed Mabworks Biotech in terms of the important clinical-stage drug candidates (MIL62, MIL93, MBS301, MIL97, MIL95, MIL86,...

Logo
251 Views
Share
28 Sep 2021 10:39

Transcenta (创胜) IPO Trading: Share Concentration

We look at the updates of Transcenta IPO since our last note. We think the debut performance is likely poor given the lack of interest and the fair...

Logo
220 Views
Share
bullishBiel Crystal
19 Sep 2021 10:10

ECM Weekly (19th September 2021) - PHC, StarHealth, TDCX, Biel Crystal, DRCBank, Transcenta, Broncus

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.

Logo
353 Views
Share
15 Sep 2021 21:17

Transcenta (创胜) IPO: Fairly Valued Despite Downsizing

We provide an update of the deal terms and the valuation for the Transcenta's book building. We think the deal is fairly valued despite its...

Logo
281 Views
Share
x